Full history for every metric is available with a Kvantra account
Boill Healthcare Holdings Limited (1246.HK)
Key financial summary
Financials in HKD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | HKD m | 106 | 217 | 1,005 | 348 | 285 | 77 | 96 |
| Operating profit | HKD m | -358 | -349 | |||||
| Net profit | HKD m | -189 | -142 | -518 | -428 | -119 | -830 | -839 |
| EPS reported | HKD | -0.61 | -0.62 | |||||
| Operating cashflow per share | HKD | -0.00 | 0.00 | |||||
| Capex per share | HKD | 0.00 | 0.00 | |||||
| FCF per share | HKD | -0.00 | 0.00 | |||||
| Free cash flow | HKD m | -5 | -103 | |||||
| Net debt | HKD m | 825 | 843 | |||||
| Book value equity | HKD m | -1,153 | -1,207 | |||||
| Book value per share | HKD | -0.85 | -0.89 | |||||
| Number of shares | m | 1,358 | 1,358 | |||||
| DPS (TTM paid) | HKD | 0.00 | 0.00 |
Financial summary
Financials in HKD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -0.02 | -0.02 | |||||
| P/S LTM | x | 0.37 | 0.30 | |||||
| P/FCF LTM | x | -5.22 | -0.28 | |||||
| EV/EBITDA LTM | x | -2.39 | -2.50 | |||||
| EV/Sales LTM | x | 11.10 | 9.07 | |||||
| Earnings Yield LTM | % | -2910.3% | -2910.3% | |||||
| FCF Yield | % | -19.17% | -361.71% | |||||
| Quality | ||||||||
| ROE | % | 71.99% | 71.00% | |||||
| ROIC | % | 98.61% | 101.91% | |||||
| Operating margin | % | -464.95% | -464.95% | |||||
| Gross margin | % | -9.10% | -9.10% | |||||
| FCF/Sales | % | -7.11% | 0.00% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -73.03% | +123.14% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -0.01 | -0.12 | |||||
| Net Debt/EBITDA | x | -2.31 | -2.40 | |||||
| EBIT/Net interest | x | -5.40 | -5.40 | |||||
| Net debt/market cap | % | 2893.9% | 2955.7% | |||||
| Net debt/Equity | x | -0.72 | -0.70 | |||||
| Gross debt/equity | x | -0.72 | -0.71 | |||||
Company overview
Boill Healthcare Holdings Limited functions as an investment holding company, primarily engaged in foundation piling contracts within Hong Kong and mainland China. Its operations are diversified across four main segments: Property Development, Healthcare Holiday Resort Development and Operation, Foundation Piling, and Securities Investment. The company's activities include developing and selling real estate, offering property management solutions, participating in securities trading and investments, and providing services such as elderly care, healthcare, and leisure experiences. It was formerly named Ngai Shun Holdings Limited, adopting its current name in September 2017. The company's headquarters are located in Central, Hong Kong.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Boill Healthcare Holdings Limited (1246.HK)
Boill Healthcare Holdings Limited functions as an investment holding company, primarily engaged in foundation piling contracts within Hong Kong and mainland China. Its operations are diversified across four main segments: Property Development, Healthcare Holiday Resort Development and Operation, Foundation Piling, and Securities Investment. The company's activities include developing and selling real estate, offering property management solutions, participating in securities trading and investments, and providing services such as elderly care, healthcare, and leisure experiences. It was formerly named Ngai Shun Holdings Limited, adopting its current name in September 2017. The company's headquarters are located in Central, Hong Kong.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free